Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Penn Medicine Cherry Hill
Penn Presbyterian Infusion Services
1865 Route 70 East
Cherry Hill, NJ 08003
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown below from a 3rd party vendor, Press Ganey and as of 7/01/21, our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Xue Jinyu, Kubicek Gregory, Patel Ashish, Goldsmith Benjamin, Asbell Sucha O, LaCouture Tamara A: Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels. Seminars in radiation oncology 26 (2): 135-9,2016.
Peterson J, Niles C, Patel A, Boujaoude Z, Abouzgheib W, Goldsmith B, Asbell S, Xu Q, Khrizman P, Kubicek G: Stereotactic Body Radiotherapy for Large (>5 cm) Non-Small-Cell Lung Cancer Clinical Lung Cancer : 2016.
Barrios, CJ, LaCouture T, Patel A, Goldsmith B, Asbell, et al.: Radiosurgery for Patients with Oligometastasis to Retroperitoneal Lymph Nodes Austin J Radiation Oncology & Cancer : 2015.
Goldsmith Benjamin, Baumann Brian C, He Jiwei, Tucker Kai, Bekelman Justin, Deville Curtiland, Vapiwala Neha, Vaughn David, Keefe Stephen M, Guzzo Thomas, Malkowicz S Bruce, Christodouleas John P: Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation. International journal of radiation oncology, biology, physics 88 (3): 603-10,2014.
Jones Joshua A, Patel Vatsal B, Goldsmith Benjamin, Teitelbaum Ursina, Plastaras John P: Diffusely metastatic digital papillary adenocarcinoma 11 years after initial presentation treated with palliative chemotherapy and radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31 (22): e386-9,2013.
Goldsmith Benjamin, Tucker Kai, Conway Robert Greg, He Jiwei, Guzzo Thomas, Bekelman Justin, Deville Curtiland, Vapiwala Neha, Malkowicz S Bruce, Christodouleas John: Discordance between preoperative and postoperative bladder cancer location: implications for partial-bladder radiation. International journal of radiation oncology, biology, physics 85 (3): 707-13,2013.
Goldsmith B, Both S, Shinkle B, James P, Hill-Kayser C, Tochner Z, Plastaras J: "A Novel Multileaf Collimator-based Photon-Proton Involved-Field Technique for Treatment of Hodgkin’s Lymphoma of the Neck and Mediastinum" Poster Presentation: American Society for Radiation Oncology Annual Meeting, 2012. Boston, MA : 2012.
Goldsmith B, Baumann B, He J, Tucker K, Bekelman J, Deville C, Vapiwala N, Guzzo T, Malkowicz B, Christodouleas J: “Common Iliac Nodal Involvement in Clinical T2 Bladder Cancer: Implications for Definitive Radiation.” Oral Presentation: American Society for Radiation Oncology Annual Meeting,2012. Boston, MA : 2012.
Caringi A, Goldsmith B, Kirk M, Both S, Rengan R, Simone C, Christodouleas J: “Combined Photon SBRT and Proton Mediastinal Radiation for Stage III Lung Cancer: The Best of Both Worlds?” Poster Presentation: Chicago Multidisciplinary Symposium in Thoracic Oncology, 2012. Chicago, IL.
Goldsmith B, Tucker K, Guzzo T, Bekelman J, Vapiwala N, Deville C, Vaughn D, Keefe S, Malkowicz SB, Christodouleas J: “Correlation of Pre-operative and Post-operative Bladder Cancer Location: Implications for Partial Bladder Radiation.” Oral Presentation: American Society for Radiation Oncology Annual Meeting, 2011. Miami, FL : 2011.
1865 Marlton Pike East
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.